- Language
-
Englisch
- Extent
-
317 Seiten
- Dimensions
-
21 cm
- Notes
-
Illustrationen
Universität Leipzig, Dissertation, 2019
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Creator
-
Hoppenz, Paul
- Event
-
Veröffentlichung
- (where)
-
Leipzig
- (when)
-
2019
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:23 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Hoppenz, Paul
Time of origin
- 2019
Other Objects (12)
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Novel cryptophycin analogues and conjugates for tumor targeted therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Metal-peptide bioconjugates for targeted anti-cancer therapy
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
About the preparation of peptide conjugates
Oligosaccharides based antibacterial drug conjugates
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Development of novel drug-like molecules for targeted therapy
Chemoselective synthesis of functional drug conjugates
Targeted drug delivery
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Novel cryptophycin analogues and conjugates for tumor targeted therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Metal-peptide bioconjugates for targeted anti-cancer therapy
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
About the preparation of peptide conjugates
Oligosaccharides based antibacterial drug conjugates
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Development of novel drug-like molecules for targeted therapy
Chemoselective synthesis of functional drug conjugates
Targeted drug delivery
Development of novel peptide-drug-conjugates for targeted breast cancer therapy
Novel cryptophycin analogues and conjugates for tumor targeted therapy
Targeting of peptide-binding receptors on cancer cells with peptide-drug conjugates
Metal-peptide bioconjugates for targeted anti-cancer therapy
Fc Antigen-Binding Fragment Drug Conjugates as Novel Antibody-Based Format for Targeted Drug Delivery
About the preparation of peptide conjugates
Oligosaccharides based antibacterial drug conjugates
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Targeted combination therapy : discovery and evaluation of synergistic anticancer effects of Anti-HER2-Duocarmycin antibody-drug conjugates combined with ATR inhibitors
Development of novel drug-like molecules for targeted therapy
Chemoselective synthesis of functional drug conjugates